Brief Screening for Mild Cognitive Impairment in Subcortical Ischemic Vascular Disease: A Comparison Study of the Montreal Cognitive Assessment with the Mini-Mental State Examination

European Neurology - Tập 71 Số 3-4 - Trang 106-114 - 2014
Qun Xu1, Wenwei Cao1, Jian-hua Mi1, Ling Yu1, Yan Lin1, Yansheng Li1
1Department of Neurology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China

Tóm tắt

<b><i>Background and Purpose:</i></b> To assess the validity of the Montreal Cognitive Assessment (MoCA) and the Mini-Mental State Examination (MMSE) in the detection of vascular mild cognitive impairment (VaMCI) in patients with subcortical ischemic vascular disease (SIVD). <b><i>Methods:</i></b> Among 102 SIVD patients, both cutoff scores of the MMSE and MoCA for differentiating VaMCI from no cognitive impairment (NCI) or differentiating VaMCI from vascular dementia (VaD) were determined by the receiver operator characteristic (ROC) analysis. Optimal sensitivity with specificity of cutoff scores was obtained after the raw scores were adjusted for education. <b><i>Results:</i></b> After adjusting for education, the MoCA cutoff score for differentiating VaMCI from NCI was at 24/25 and that for differentiating VaMCI from VaD was at 18/19. After applying the adjusted MoCA scores from 19 to 24 to identify VaMCI in all SIVD patients, sensitivity was at 76.7% and specificity was at 81.4% (&#954; = 0.579). The adjusted cutoff score of the MMSE for differentiating VaMCI from NCI was at 28/29 and that for differentiating VaMCI from VaD was at 25/26. The sensitivity and specificity of the adjusted MMSE was at 58.1 and 71.2%, respectively, when using the score from 26 to 28 to identify VaMCI in SIVD patients (&#954; = 0.294). <b><i>Conclusions:</i></b> The MoCA detected subcortical VaMCI better than the MMSE.

Từ khóa


Tài liệu tham khảo

10.1161/STR.0b013e3182299496

10.1016/0022-3956(75)90026-6

10.1093/ageing/31.6.451

10.1017/S1041610205002711

10.1111/j.1532-5415.2005.53221.x

10.1111/j.1447-0594.2010.00585.x

10.1161/01.STR.0000237236.88823.47

10.1007/978-3-7091-6781-6_4

10.1016/S1474-4422(02)00190-4

10.1016/S1474-4422(08)70040-1

10.1016/S1098-3597(01)90047-X

10.1159/000083499

10.1159/000081050

10.1212/WNL.34.7.939

10.1097/WAD.0b013e3181999e92

10.1001/jama.1963.03060120024016

10.1159/000320491

10.1007/s00401-006-0185-2

10.1136/jnnp.2005.069120

10.1016/j.jns.2010.08.051

10.1161/STROKEAHA.110.579888

10.1161/STROKEAHA.111.633586

10.1159/000338905

10.1016/j.jstrokecerebrovasdis.2012.01.001

10.1159/000340047

10.1159/000232589

10.1017/S135561771200077X

10.1161/STROKEAHA.110.606277

10.1177/0891988708316855

10.1002/gps.2101

10.1159/000323867

10.1161/01.STR.29.1.75